Literature DB >> 11389612

Baccatin III induces assembly of purified tubulin into long microtubules.

S K Chatterjee1, D M Barron, S Vos, S Bane.   

Abstract

Baccatin III is widely considered to be an inactive derivative of Taxol. We have reexamined its effect on in vitro assembly of tubulin under a variety of conditions. We found baccatin III to be active in all circumstances in which Taxol is active: it assembled GTP-tubulin, GDP-tubulin, and microtubule protein into normal microtubules and stabilized these polymers against cold-induced disassembly. The effect of baccatin III on in vitro microtubule assembly was quantitatively assessed through determination of critical concentrations, which can be used to obtain the apparent equilibrium constants for the addition of tubulin subunits to growing microtubules. The apparent equilibrium constants for the growth reaction for baccatin III-induced GTP-tubulin and GDP-tubulin assembly measured at 37 degrees C were 4.2-4.6-fold less than those measured for Taxol-induced GTP-tubulin and GDP-tubulin assembly. These data indicate that the entire Taxol side chain contributes only about -1 kcal/mol to the apparent standard free energy of microtubule growth at 37 degrees C regardless of the nature of the E site nucleotide. These data also support the idea that the majority of the interactions between Taxol and tubulin that affect this equilibrium occur between the baccatin portion of the molecule and the binding site. We have also observed a structural difference in microtubules formed using baccatin III and Taxol. Baccatin III-induced microtubules were routinely much longer than those assembled by Taxol, even when very high concentrations of baccatin III were employed. One interpretation of these data is that baccatin III and Taxol differ in their abilities to nucleate GTP-tubulin. This difference in activity may have bearing on the large disparity in cytotoxicity of the two molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389612     DOI: 10.1021/bi002816i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.

Authors:  Thota Ganesh; Chao Yang; Andrew Norris; Tom Glass; Susan Bane; Rudravajhala Ravindra; Abhijit Banerjee; Belhu Metaferia; Shala L Thomas; Paraskevi Giannakakou; Ana A Alcaraz; Ami S Lakdawala; James P Snyder; David G I Kingston
Journal:  J Med Chem       Date:  2007-01-31       Impact factor: 7.446

2.  Promotion of tubulin assembly by poorly soluble taxol analogs.

Authors:  Shubhada Sharma; Thota Ganesh; David G I Kingston; Susan Bane
Journal:  Anal Biochem       Date:  2006-10-30       Impact factor: 3.365

3.  Synthesis and bioactivity of a side chain bridged paclitaxel: A test of the T-Taxol conformation.

Authors:  Mathis Hodge; Qiao-Hong Chen; Susan Bane; Shubhada Sharma; Maura Loew; Abhijit Banerjee; Ana A Alcaraz; James P Snyder; David G I Kingston
Journal:  Bioorg Med Chem Lett       Date:  2009-03-21       Impact factor: 2.823

4.  Dissecting paclitaxel-microtubule association: quantitative assessment of the 2'-OH group.

Authors:  Shubhada Sharma; Chandraiah Lagisetti; Barbara Poliks; Robert M Coates; David G I Kingston; Susan Bane
Journal:  Biochemistry       Date:  2013-03-19       Impact factor: 3.162

5.  Design, synthesis and biological evaluation of bridged epothilone D analogues.

Authors:  Qiao-Hong Chen; Thota Ganesh; Peggy Brodie; Carla Slebodnick; Yi Jiang; Abhijit Banerjee; Susan Bane; James P Snyder; David G I Kingston
Journal:  Org Biomol Chem       Date:  2008-11-06       Impact factor: 3.876

6.  Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani.

Authors:  Balabhadrapatruni Vsk Chakravarthi; Ramanathan Sujay; Gini C Kuriakose; Anjali A Karande; Chelliah Jayabaskaran
Journal:  Cancer Cell Int       Date:  2013-10-23       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.